当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 利润表

复星医药

(600196)

29.15

0.54  (1.89%)

今开:28.93最高:29.68成交:16.57万手 市盈:0.00 上证指数:3250.60   0.39%2017-07-24
昨收:28.61 最低:28.93 换手:0.00%振幅:0.00 深证指数:10404.22  0.38%15:28:59

集合

竞价

利润表

按照会计年度查询:
报告期2016-12-312016-09-302016-06-302016-03-31
一、营业总收入14,628,820,443.0710,637,985,4626,937,091,238.453,226,040,690.52
营业收入14,628,820,443.0710,637,985,4626,937,091,238.453,226,040,690.52
二、营业总成本13,367,106,291.079,512,363,248.736,159,446,501.122,888,139,056.9
营业成本6,718,363,996.864,915,105,208.323,228,574,506.971,560,156,697
营业税金及附加152,543,484.3686,547,506.2859,225,933.4626,138,487.73
销售费用3,704,056,389.722,639,501,550.341,679,760,685.16758,025,326.1
管理费用2,311,856,850.81,525,389,484.26970,947,149.23442,287,426.3
财务费用400,940,311.75319,329,904.69198,372,474.29100,816,157.02
资产减值损失79,345,257.5826,489,594.8422,565,752.01714,962.75
三、其他经营收益-72,139,251.64-169,063,311.66-78,201,676.16-93,184,270.62
允许价值变动净收益12,301,174.023,345,092.31-7,414,661.04-4,713,785.57
投资净收益2,125,400,785.571,565,442,784.231,078,798,670.82491,892,235.07
联营、合营企业投资收益1,342,807,937.571,035,810,577.66717,195,928.76276,926,240.79
汇兑净收益--------
四、营业利润3,399,416,111.592,694,410,089.811,849,028,747.11825,080,083.12
营业外收入195,112,995.42157,664,123.7287,474,740.9133,381,355.27
营业外支出22,980,280.5914,266,811.616,732,791.24892,739.61
非流动资产处置净损失9,738,085.735,404,663.433,686,774.12160,554.36
五、利润总额3,571,548,826.422,837,807,401.921,929,770,696.78857,568,698.78
所得税350,207,030.72305,000,525.21181,145,208.295,758,837.62
未确认的投资损失--------
六、净利润(百万元)2,176.891,500.27634.232,460.09
少数股东损益415,504,724.35355,918,128.76248,359,081.01127,578,035.45
归属于母公司股东的净利润2,805,837,071.352,176,888,747.951,500,266,407.57634,231,825.71
七、每股收益--0.940.650.27
基本每股收益1.210.940.650.27
稀释每股收益1.20.940.650.27
TOP↑